Adagene Inc - ADAG Company Short-Term Debt

Graphic logo of Adagene (ADAG)

Adagene business growth depends on antibody test outcomes and partner payments amid stable cash reserves. Research centers in the US and China rely on external manufacturing plants for drug production. This short-term debt chart demonstrates the impact of the NEObody platform on financial stability, with the indicator reaching 0.00, confirming the precision of AI-driven drug design.

ADAG (adagene.com) Company Short-Term Debts history from 07/04/2022 to 10/29/2026

Adagene Inc - analytical breakdowns and key metrics (ADAG)

- price and consensus price forecast:
Price Chart Adagene Corp|ADAG - Fair Value Consensus
- market capitalization data:
Market Value Adagene Inc.|ADAG - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Adagene|ADAG - Book Capitalization|Market Cap to Net Assets Ratio adagene.com|ADAG - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Adagene|ADAG - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Adagene Corp|ADAG - Company Total Debt|Debt to Book Capitalization Ratio Adagene Inc.|ADAG - Company Long-Term Liabilities|Company Current Liabilities Adagene
Fundamental company valuation:adagene.com - ADAG
Product sample of Adagene Corp

This indicator measures the total volume of liabilities with a maturity of up to one year, reflecting management's ability to manage liquidity and minimize default risks. The stability of current loans and borrowings confirms that Adagene effectively funds R&D through partner payments and licensing fees, maintaining financial equilibrium without a critical dependence on short-term debt capital.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Celldex Corp - Short-Term Debt Volume|AUPH: Company Short-Term Debt|BCRX: Company Current Liabilities|VERA (Vera Therapeutics) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Company Current Liabilities|Company Short-Term Debts ABCL|Company Short-Term Debt Tourmaline Bio, Inc. TRML|Company Short-Term Indebtedness precigen.com (PGEN)|PHAR: Company Short-Term Debts|Short-Term Debt Nektar Therapeutics Inc NKTR|Upstream Bio Corp - Company Short-Term Debts|ZBIO - Company Short-Term Debts|Company Short-Term Debts Immunome, Inc.|gossamerbio.com (GOSS) - Company Short-Term Indebtedness|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|Company Short-Term Debts Septerna, Inc.|PVLA: Company Short-Term Debts|Short-Term Indebtedness Savara Pharma (SVRA)|RIGL: Company Short-Term Debts|anaptysbio.com - Short-Term Debt|Astria Therapeutics, Inc. (ATXS) - Company Short-Term Debt|ENGN - Company Short-Term Indebtedness|Company Short-Term Debts RAPT|Aerovate Therapeutics (JBIO) - Short-Term Debt|ACRS (Aclaris Therapeutics) - Company Short-Term Debts|Company Short-Term Debts kyvernatx.com|Company Short-Term Debts Tiziana Life Sciences Ltd TLSA|Company Short-Term Indebtedness Cabaletta Bio Inc. (CABA)|Company Short-Term Debts VTYX (Ventyx Bio)|Company Short-Term Debts Theratechnologies, Inc THTX|Company Short-Term Debts AVTX|ELDN: Short-Term Indebtedness|Company Short-Term Debt Agenus Inc. (AGEN)|Climb Bio Inc. (CLYM) - Current Liabilities|ZURA - Company Short-Term Debts|Company Short-Term Loans and Borrowings aTyr Pharmaceuticals|Company Short-Term Debts IMA|Company Short-Term Debts STTK (shattucklabs.com)|Company Short-Term Debt Equillium|Connect Biopharma Holdings - Company Short-Term Loans and Borrowings|IMUX: Company Short-Term Debt|ATRA - Company Current Liabilities|IFRX: Company Short-Term Debts|Company Short-Term Debts x4pharma.com|ACET - Company Current Liabilities|Company Short-Term Loans and Borrowings Celularity Corp|INMB (INmune Bio Corp) - Company Short-Term Debts|Short-Term Debt Volume BRNS (Barinthus Biotherapeutics Corp)|Kezar Life Sciences - Company Short-Term Debt|sabbiotherapeutics.com - Company Current Liabilities|AKTX: Company Short-Term Debt|Enlivex Therapeutics (ENLV) - Company Current Liabilities|QTTB: Company Current Liabilities|GOVX (GeoVax Corp) - Company Short-Term Debts|Company Short-Term Debt Edesa Biotech, Inc. (EDSA)|Company Short-Term Indebtedness ibioinc.com|Carisma Therapeutics - Company Short-Term Debts|Short-Term Debt XTL Biopharmaceuticals Ltd (XTLB)|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Short-Term Debts HCW Biologics, Inc. HCWB|Aptevo (APVO) - Company Short-Term Debts|AIM - Company Short-Term Indebtedness|ADTX: Company Short-Term Debts|GRI Bio Inc (GRI) - Company Short-Term Debts|XORTX - Company Short-Term Debts|Short-Term Indebtedness Vyome Therapeutics|Revelation Biosciences - Company Short-Term Debts|Short-Term Debt INDP (indaptusrx.com)|SCNI - Company Short-Term Debt|Company Short-Term Indebtedness CalciMedica Inc CALI|AFMD (Affimed Therapeutics) - Company Short-Term Debts|ALLK - Short-Term Debt|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Short-Term Debts iTeos Therapeutics, Inc. (ITOS)|Company Short-Term Indebtedness Ocean Biomedical Inc|Company Short-Term Debts TCBP|Company Short-Term Debts Third Harmonic Bio Inc (THRD)